Tim Johnson

Title: Tim Johnson: Innovator in Medical Antibodies

Introduction

Tim Johnson is a notable inventor based in Sheffield, GB. He has made significant contributions to the field of medical science, particularly through his work on antibodies that target transglutaminase type 2 (TG2). With a total of 3 patents, his innovations are paving the way for advancements in the treatment of various medical conditions.

Latest Patents

Among his latest patents, Tim Johnson has developed anti-transglutaminase 2 antibodies. This invention provides antibodies and antigen-binding fragments that selectively bind to an epitope within the core region of TG2. The novel epitopes within the TG2 core are crucial for the development of human TG2 inhibitory antibodies. These antibodies have potential applications in medicine, particularly for the treatment and diagnosis of conditions such as Celiac disease, scarring, fibrosis-related diseases, neurodegenerative and neurological diseases, and cancer.

Career Highlights

Tim Johnson is currently associated with Lifearc, where he continues to innovate and contribute to the field of medical research. His work has garnered attention for its potential impact on healthcare and patient outcomes.

Collaborations

Tim collaborates with notable colleagues, including Phil Watson and David Matthews, who share his commitment to advancing medical science through innovative research.

Conclusion

Tim Johnson's contributions to the field of medical antibodies exemplify the importance of innovation in healthcare. His work not only enhances our understanding of complex diseases but also opens new avenues for treatment.